v3.24.1.1.u2
EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 16, 2023
Mar. 29, 2021
Jun. 22, 2020
Mar. 15, 2020
Feb. 29, 2020
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Jan. 20, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock shares authorized           300,000,000     300,000,000 300,000,000  
Common stock par value, per share           $ 0.001     $ 0.001 $ 0.001  
Options grant during the period               986,000 479,000  
Weighted average exercise price               $ 3.15 $ 4.50  
Underlying value of ordinary shares                 $ 3    
Expected volatility minimum                 88.00%    
Expected volatility maximum                 90.00%    
Term of the options (years)                 7 years    
Risk-free interest rate minimum                 3.93%    
Risk-free interest rate maximum                 4.47%    
Compensation expense           $ 500 $ 348   $ 1,664 $ 1,638  
Share-Based Payment Arrangement, Option [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized                 260,000    
Share-Based Payment Arrangement, Option [Member] | Prof Goldwasser [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized                 150,000 45,000  
Equity Option [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Weighted average exercise price                 $ 2.37    
Stock option award cost not yet recognized                 $ 1,930    
Stock option award weighted average period                 1 year 4 months 17 days    
Restricted Stock Units (RSUs) [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Options grant during the period                 25,000    
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value                 $ 75    
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value                 $ 70    
Estimated average period                 1 year 1 month 24 days    
Minimum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price ($)                 $ 3    
Maximum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price ($)                 $ 4.5    
2020 Share Incentive Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Options grant during the period                 986,000 479,000  
Stock option vested term                 7 years    
2020 Share Incentive Plan [Member] | Minimum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock option vested term                 3 years    
2020 Share Incentive Plan [Member] | Maximum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock option vested term                 4 years    
Stock Purchase Agreements [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of units 3,294,117                    
Purchase price $ 4.25                    
Aggregate purchase price $ 14,000                    
Stock Purchase Agreements [Member] | Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock par value, per share $ 0.001                    
Stock Purchase Agreements [Member] | Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price $ 5.50                    
Board of Directors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock shares authorized                     225,000,000
Common stock par value, per share                     $ 0.001
Board of Directors [Member] | 2020 Share Incentive Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Options grant during the period       64,099     1,000,000 777,778      
Investment C [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of units   2,469,156                  
Investors C [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Proceeds from issuance of common stock   $ 20,000                  
Sale of stock, description   Each such unit consists of (i) one share of common stock and (ii) one warrant to purchase one share of common stock with an exercise price of $10.35 per share.                  
Exercise price   $ 10.35                  
Warrants and rights outstanding, maturity date   Mar. 31, 2026                  
Common stock percent   135.00%                  
Employees, Consultants, Directors and Other Service Providers [Member] | 2020 Share Incentive Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Options grant during the period     401,950   580,890            
Officer [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized                 225,000 400,000  
Employee and Directors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Compensation expense                 $ 1,664 $ 1,638